First case series reported in Colombia of primary and secondary cold agglutinin disease. Experience of a reference center in Medellín between 2010 and 2017

Introduction: Cold agglutinin disease (CAD) is a primary hematologic disorder or can be secondary to another disease. CAD is characterized by autoim-mune hemolytic anemia associated with IgM type antibodies, at low temperatures. Clinically CAD is associated with cryoparesth...

Full description

Bibliographic Details
Main Author: Quintero, Catalina
Format: Article
Language:Spanish
Published: Universidad de Antioquia 2020-04-01
Series:Iatreia
Subjects:
Online Access:https://revistas.udea.edu.co/index.php/iatreia/article/view/336943/20802235
_version_ 1828450711714660352
author Quintero, Catalina
author_facet Quintero, Catalina
author_sort Quintero, Catalina
collection DOAJ
description Introduction: Cold agglutinin disease (CAD) is a primary hematologic disorder or can be secondary to another disease. CAD is characterized by autoim-mune hemolytic anemia associated with IgM type antibodies, at low temperatures. Clinically CAD is associated with cryoparesthesia and acrocyanosis induced by cold and fever, or it can be asymptomatic and can be detected by abnormalities on cell blood counts. Objective: To describe the clinical and laboratory data and the etiology of CAD. Comparison between this case series and those described in the literature. Materials and Methods: Retrospectively, we analy-zed clinical data of patients from Hospital Universi-tario San Vicente Fundación with positive results for cold agglutinin assays made in the hematology lab from Universidad de Antioquia. We consider patients with titers ≥ 1:64 or Coombs test positive for cold an-tibodies. Results: We describe clinical and laboratory findings included crioagglutinin titers of 23 cases with CAD: 6 of them with primary CAD, 4 with non-Hodgkin Lym-phoma (NHL), 8 patients with CAD associated with infectious and autoimmune disease and 5 with CAD miscellaneous diseases. Disscusion and Conclusions: This is the first CAD case series described in Colombia. Age and gender were like others case series. Most of patients presented with hemolityc anemia and cold related symptoms. The hemoglobin/ hematocrit ratio was 1:2. Secondary causes were vasculitis, lupus and malaria. Primary CAD were related to NHL, specifically limphoplasmo-cytic Most of the treatments of primary CAD included rituximab.
first_indexed 2024-12-10T23:26:24Z
format Article
id doaj.art-85a2c1062707423485dc8f30770e90aa
institution Directory Open Access Journal
issn 0121-0793
2011-7965
language Spanish
last_indexed 2024-12-10T23:26:24Z
publishDate 2020-04-01
publisher Universidad de Antioquia
record_format Article
series Iatreia
spelling doaj.art-85a2c1062707423485dc8f30770e90aa2022-12-22T01:29:34ZspaUniversidad de AntioquiaIatreia0121-07932011-79652020-04-0133212313210.17533/udea.iatreia.40First case series reported in Colombia of primary and secondary cold agglutinin disease. Experience of a reference center in Medellín between 2010 and 2017Quintero, Catalina 0https://orcid.org/0000-0003-1721-7567Universidad de AntioquiaIntroduction: Cold agglutinin disease (CAD) is a primary hematologic disorder or can be secondary to another disease. CAD is characterized by autoim-mune hemolytic anemia associated with IgM type antibodies, at low temperatures. Clinically CAD is associated with cryoparesthesia and acrocyanosis induced by cold and fever, or it can be asymptomatic and can be detected by abnormalities on cell blood counts. Objective: To describe the clinical and laboratory data and the etiology of CAD. Comparison between this case series and those described in the literature. Materials and Methods: Retrospectively, we analy-zed clinical data of patients from Hospital Universi-tario San Vicente Fundación with positive results for cold agglutinin assays made in the hematology lab from Universidad de Antioquia. We consider patients with titers ≥ 1:64 or Coombs test positive for cold an-tibodies. Results: We describe clinical and laboratory findings included crioagglutinin titers of 23 cases with CAD: 6 of them with primary CAD, 4 with non-Hodgkin Lym-phoma (NHL), 8 patients with CAD associated with infectious and autoimmune disease and 5 with CAD miscellaneous diseases. Disscusion and Conclusions: This is the first CAD case series described in Colombia. Age and gender were like others case series. Most of patients presented with hemolityc anemia and cold related symptoms. The hemoglobin/ hematocrit ratio was 1:2. Secondary causes were vasculitis, lupus and malaria. Primary CAD were related to NHL, specifically limphoplasmo-cytic Most of the treatments of primary CAD included rituximab.https://revistas.udea.edu.co/index.php/iatreia/article/view/336943/20802235autoimmune hemolytic anemiacold agglutinin diseaselymphomahematologic neoplasmsrituximab
spellingShingle Quintero, Catalina
First case series reported in Colombia of primary and secondary cold agglutinin disease. Experience of a reference center in Medellín between 2010 and 2017
Iatreia
autoimmune hemolytic anemia
cold agglutinin disease
lymphoma
hematologic neoplasms
rituximab
title First case series reported in Colombia of primary and secondary cold agglutinin disease. Experience of a reference center in Medellín between 2010 and 2017
title_full First case series reported in Colombia of primary and secondary cold agglutinin disease. Experience of a reference center in Medellín between 2010 and 2017
title_fullStr First case series reported in Colombia of primary and secondary cold agglutinin disease. Experience of a reference center in Medellín between 2010 and 2017
title_full_unstemmed First case series reported in Colombia of primary and secondary cold agglutinin disease. Experience of a reference center in Medellín between 2010 and 2017
title_short First case series reported in Colombia of primary and secondary cold agglutinin disease. Experience of a reference center in Medellín between 2010 and 2017
title_sort first case series reported in colombia of primary and secondary cold agglutinin disease experience of a reference center in medellin between 2010 and 2017
topic autoimmune hemolytic anemia
cold agglutinin disease
lymphoma
hematologic neoplasms
rituximab
url https://revistas.udea.edu.co/index.php/iatreia/article/view/336943/20802235
work_keys_str_mv AT quinterocatalina firstcaseseriesreportedincolombiaofprimaryandsecondarycoldagglutinindiseaseexperienceofareferencecenterinmedellinbetween2010and2017